Salivary Gland Infection Market Report 2026

Salivary Gland Infection Market Overview

• Salivary Gland Infection market size has reached to $4.45 billion in 2025 • Expected to grow to $6.5 billion in 2030 at a compound annual growth rate (CAGR) of 7.8% • Growth Driver: Impact Of Rising Oral Health Issues On Infection Rates • Market Trend: Advancing Treatment With Minimally Invasive Innovations • North America was the largest region in 2025.

What Is Covered Under Salivary Gland Infection Market?

Salivary gland infections are bacterial or viral infections that affect the salivary glands, leading to symptoms such as swelling, pain, and dry mouth. These infections occur in major glands such as the parotid, submandibular, and sublingual glands. They result from blockage, dehydration, or infections such as mumps. The main diagnosis for the salivary gland infection are plain radiography, sialography, computed tomography (CT), magnetic resonance imaging (MRI), radionuclide scintigraphy, high-resolution ultrasonography, and other diagnostic techniques. Plain radiography is an imaging method that utilizes X-rays to produce images of internal body structures, including salivary glands, and is used to identify stones or calcifications in the glands. Treatment options encompass medications, surgery, aspiration, home care, and other therapies. These services are provided in hospitals and clinics, medical research centres, academic institutions, and other end-user settings.

What Is The Salivary Gland Infection Market Growth Forecast?

The salivary gland infection market size is expected to see strong growth in the next few years. It will grow to $6.5 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing demand for advanced diagnostic accuracy, rising investments in ENT diagnostic tools, expansion of outpatient diagnostic services, growing focus on patient-centric treatment pathways, increasing integration of imaging and laboratory diagnostics. Major trends in the forecast period include increasing use of advanced imaging diagnostics, rising adoption of targeted antibiotic therapies, growing focus on early infection detection, expansion of minimally invasive treatment approaches, enhanced emphasis on comprehensive diagnostic pathways.

Global Salivary Gland Infection Market Segmentation

1) By Diagnosis: Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses 2) By Treatment: Medications, Surgery, Aspiration, Home Care, Other Treatments 3) By End User: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User Subsegments: 1) By Plain Radiography: X-ray Of Salivary Glands, Sialography With X-ray 2) By Sialography: Conventional Sialography, Digital Subtraction Sialography (DSS) 3) By Computed Tomography (CT): Non-contrast CT, Contrast-enhanced CT 4) By Magnetic Resonance Imaging (MRI): MRI without contrast, MRI With contrast (Dynamic MRI) 5) By Radionuclide Scintigraphy: Planar Scintigraphy, SPECT (Single Photon Emission Computed Tomography) 6) By High-resolution Ultrasonography: Standard Ultrasonography, Doppler Ultrasonography 7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy, Endoscopy, Salivary Flow Test

What Are The Drivers Of The Salivary Gland Infection Market?

The rise in oral health issues is expected to drive the growth of salivary gland infections market going forward. Oral health issues include conditions such as tooth decay, gum infections, and other mouth-related problems. Poor oral hygiene, unhealthy eating habits, and inadequate dental care access are driving the rise in oral health problems. The rise in oral health issues increases the risk of salivary gland infections by promoting bacterial growth and blockages in the salivary ducts. For instance, in May 2024, according to the National Health Service (NHS), a UK-based government agency, in 2022-23, 32.5 million dental treatments were provided, reflecting a 23.2% increase compared to the previous year. Therefore, the rise in oral health issues is driving the growth of the salivary gland infections industry. The growing demand for minimally invasive surgery is expected to drive the growth of salivary gland infections market going forward. Minimally invasive surgery is a method that uses small cuts and advanced tools to perform procedures with less pain, faster healing, and smaller scars than conventional surgery. The rise of minimally invasive surgery is driven by its advantages, such as less pain, faster recovery, and fewer risks, along with technological advancements such as robotics and laparoscopic equipment that improve precision and patient results. Minimally invasive surgery treats salivary gland infections by using small incisions and specialized tools to drain abscesses or remove blockages, reducing recovery time and complications. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, reported that in 2023, minimally invasive procedures saw a 7% increase compared to the previous year. Therefore, the growing demand for minimally invasive surgery is driving the salivary gland infections industry.

Key Players In The Global Salivary Gland Infection Market

Major companies operating in the salivary gland infection market are Pfizer Inc., Johnson And Johnson, Roche Holding AG, Merck And Co Inc, AbbVie Inc, AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly And Company, FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim GmbH, Astellas Pharma Inc, Sandoz International GmbH, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc, Mylan NV, Zydus Cadila Healthcare Ltd, Sun Pharmaceutical Industries Ltd, Dr Reddys Laboratories Ltd, Cipla Limited, Sanofi SA, Bayer AG, Perrigo Company plc

Global Salivary Gland Infection Market Trends and Insights

Major companies operating in the salivary gland infections market are prioritizing technological advancements, particularly in minimally invasive procedures, to improve treatment outcomes, accelerate patient recovery, and enhance overall healthcare efficiency. Minimally invasive procedures involve smaller incisions and specialized tools, causing less tissue damage and promoting faster recovery. For instance, in March 2024, Amrita Hospital, an India-based healthcare institution, launched the Amrita Centre for minimally invasive salivary gland surgery, offering a groundbreaking treatment for salivary disorders through endoscopy, minimizing the need for surgery and preserving glandular function. The launch was highlighted by a two-day workshop showcasing expert demonstrations.

Regional Outlook

North America was the largest region in the salivary gland infection market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Salivary Gland Infection Market?

The salivary gland infections market consists of revenues earned by entities by providing services such as ultrasound, rehabilitation therapy, and glandular duct dilation procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The salivary gland infections market includes sales of antibiotics, antiviral drugs, anti-inflammatory medications, and biocompatible stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Salivary Gland Infection Market Report 2026?

The salivary gland infection market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the salivary gland infection industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.